Reference Portfolio · Updated

Hypergrowth

Closelook Hypergrowth reference portfolio — AI-native, agentic software, and the Rubin Build-Out complex.

Since inception +19.35% From Feb 13, 2026
YTD 2026 +19.35% Same period as since inception
Holdings 23
Benchmark QQQ
Currencies USD
Inception Feb 13, 2026 USD 250,000 starting capital

Thesis

Closelook Hypergrowth holds the high-conviction equity positions on AI-native and agentic-software names. Constituents are drawn from the overlap of three Closelook frameworks: HALO Growth 100 (AI-immunity leaders), AW25 (the agentic-software 25), and the high-AI-beta subset of Rubin Build-Out. Position sizes are meaningful — this is not a diversified basket, it's a concentrated view on the companies best-positioned for the agentic era.

A covered-call layer sits on top of the stock positions when implied volatility and distance-to-resistance allow constructive premium capture. The call-writing layer is documented in the Derivatives reference portfolio — together they form one income-aware hypergrowth sleeve.

Rebalancing is driven by the AI Immunity score, AW25 constituent reviews, and Rubin sentinel confirmations. When a name's AI Immunity degrades or the sentinel structure breaks, we trim before the broader market has repriced.

Structure

  • Equities19
  • Equity Options3
  • Cash1

19 equity positions · 3 option positions . Benchmark: Nasdaq 100 (QQQ).

Top Holdings

20 total positions — top 10 by weight shown. Barchart snapshot from Aug 14, 2026.

# Symbol Name Weight
1 NBIS 13.65%
2 NET 7.76%
3 DDOG 6.28%
4 NVDA 5.54%
5 TSM 5.26%
6 ASX 4.90%
7 MU 4.78%
8 LLY 4.36%
9 PLTR 4.28%
10 QCOM 4.09%

Related

Closelook C+ Portfolio

Real-time access for founding subscribers

Free readers see this end-of-day snapshot of the top positions. Founding subscribers also get every position with cost basis and per-position P&L, the full trade log in real time as moves happen, and the long-form weekly commentary that explains every change.

  • Every position with cost basis, market value, and unrealized P&L
  • Real-time trade log (free readers see weekly digest)
  • Long-form commentary with the rationale behind every move
  • Push notifications when positions open, close, or resize
Become a founding subscriber → $25/mo · $250/yr · founding rate

Methodology & disclaimer

Hypergrowth is a reference portfolio — it reflects how Thomas Look, author and publisher of Closelook, implements the analytical theses discussed on this site. Position data is updated daily from end-of-day broker exports (Barchart). Benchmark prices come from EODHD.

Reference portfolio, educational purpose only. Concentration by design — not diversified.

Reference portfolio, not investment advice. Past performance is not indicative of future results. Closelook Venture GmbH is a publishing company and does not manage client capital.

FAQ · from the current data · as of 2026-08-14

Hypergrowth — Q&A

What is the Hypergrowth reference portfolio?

Closelook Hypergrowth reference portfolio — AI-native, agentic software, and the Rubin Build-Out complex. A live model book mirrored 1:1 from broker exports and published as part of the Closelook investment diary — 20 positions as of Aug 14, 2026, running since Feb 13, 2026. Not investment advice.

What are the largest positions in Hypergrowth?

As of Aug 14, 2026, by weight (cash excluded): NBIS 13.7%, NET 7.8%, DDOG 6.3%, NVDA 5.5%, TSM 5.3%. The top 10 are public; the full composition with cost basis and unrealised P&L is subscriber-only.

How has Hypergrowth performed?

+19.35% since inception (Feb 13, 2026), measured as net liquidation value against deposited capital on the latest weekly snapshot (Aug 14, 2026). Past performance is no indication of future performance.

How often is the book updated, and is this advice?

Snapshots are taken from the broker export at the Friday close and published weekly; every Add, Reduce, Roll and Exit is logged on the Signal desk trade log with the reasoning. Closelook publishes an investment research diary, not investment advice.